Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Clinical research sponsor

Published trials27
Recruiting shown11
Roles2
SourceClinicalTrials.gov

Clinical trials

27 shown
A Study of HDM2020 in Patients With Advanced Sq-NSCLCNCT07638891 · lead sponsor · 2026-04-01
RECRUITING
Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesNCT07521631 · lead sponsor · 2026-03-31
RECRUITING
A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneNCT07394114 · lead sponsor · 2026-02-24
RECRUITING
Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without DiabetesNCT07279194 · lead sponsor · 2025-10-14
RECRUITING
A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinNCT07331389 · lead sponsor · 2025-09-24
RECRUITING
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusNCT07193459 · lead sponsor · 2025-08-12
RECRUITING
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusNCT07082114 · lead sponsor · 2025-07-14
RECRUITING
A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminNCT07109700 · lead sponsor · 2025-04-30
RECRUITING
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlNCT07244003 · lead sponsor · 2025-03-29
RECRUITING
Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes MellitusNCT06886126 · lead sponsor · 2025-02-07
RECRUITING
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese PatientsNCT07036172 · lead sponsor · 2025-01-03
RECRUITING
A Pharmacokinetic Study of HDM1005 Injection at Different Injection SitesNCT07828197 · lead sponsor · 2026-09-03
ACTIVE_NOT_RECRUITING
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) TherapyNCT07794397 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) TherapyNCT07787260 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy ParticipantsNCT07559240 · lead sponsor · 2026-05-15
NOT_YET_RECRUITING
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNCT07502001 · lead sponsor · 2026-04-08
NOT_YET_RECRUITING
A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorNCT07417306 · lead sponsor · 2026-03-27
NOT_YET_RECRUITING
Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNCT07116928 · lead sponsor · 2025-11-30
NOT_YET_RECRUITING
Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsNCT06885021 · lead sponsor · 2025-03-28
NOT_YET_RECRUITING
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.NCT06634927 · lead sponsor · 2024-09-22
COMPLETED
HDM1002 Tablets in Chinese Overweight and Obese Adult SubjectsNCT06520540 · lead sponsor · 2024-07-28
UNKNOWN
Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese AdultsNCT06500299 · lead sponsor · 2024-07-15
UNKNOWN
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusNCT06481085 · lead sponsor · 2024-06-27
COMPLETED
Phase Ib Clinical Study of HDM1005 InjectionNCT06637020 · lead sponsor · 2024-06-21
COMPLETED
Phase Ia Clinical Study of HDM1005 InjectionNCT06640647 · lead sponsor · 2024-03-19
COMPLETED
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 DiabetesNCT06739044 · lead sponsor · 2023-09-20
COMPLETED
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseNCT06501326 · collaborator · 2023-11-01
UNKNOWN

Sponsor roles

lead sponsor26
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.